Skip Navigation LinksHome > March 2014 - Volume 36 - Issue 2 > A Rare Type of Secondary Cancer in a Child With Acute Lympho...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318290c65c
Online Articles: Clinical and Laboratory Observations

A Rare Type of Secondary Cancer in a Child With Acute Lymphoblastic Leukemia: Malignant Fibrous Histiocytoma

İncesoy Özdemir, Sonay MD; Balkaya, Eda MD; Ören, Ayşe C. MD; Bozkurt, Ceyhun MD; Şahin, Gürses MD; Ünlü, Ramazan E. MD; Ertem, Ayşe U. MD

Collapse Box


Secondary cancers which are related with treatment of childhood acute lymphoblastic leukemia (ALL) is a significant problem with longer term. For development of secondary cancer after treatment, the latency period varies between 5 and 10 years. In this case, a 13 year-old-boy diagnosed as high-risk ALL was treated with chemotherapy and prophylactic cranial radiotherapy at a dose of 1800 cGy. Six years after the end of treatment he developed a 5×5×4 cm mass at the right temporal region of the cranium. The mass was excised totally with clear surgical margin. Pathology of mass has been diagnosed as malignant fibrous histiocytoma (MFH), recently referred to as an undifferentiated pleomorphic sarcoma (UPS). After treatment of childhood ALL, reported cases of secondary MFH is extremely rare in the literature. Herein we present a case of MFH/UPS that developed as a secondary cancer 6 years after the end of ALL treatment.

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.